<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Morris O</submitter><funding>Medical Research Council</funding><funding>Alzheimers Research UK</funding><funding>GE Healthcare</funding><funding>MRC</funding><pagination>120-7</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5034901</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>116</volume><pubmed_abstract>2-[(18)F]-Fluoro-3-pyridinecarboxaldehyde ([(18)F]FPCA) is a novel, water-soluble prosthetic group. It's radiochemistry has been developed and fully-automated for application in chemoselective radiolabelling of amino(oxy)-derivatised RI-OR2-TAT peptide, (Aoa-k)-RI-OR2-TAT, using a GE TRACERlab FX-FN. RI-OR2-TAT is a brain-penetrant, retro-inverso peptide that binds to amyloid species associated with Alzheimer's Disease. Radiolabelled (Aoa-k)-RI-OR2-TAT was reproducibly synthesised and the product of the reaction with FPCA has been fully characterised. In-vivo biodistribution of [(18)F]RI-OR2-TAT has been measured in Wistar rats.</pubmed_abstract><journal>Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine</journal><pubmed_title>Development &amp; automation of a novel [(18)F]F prosthetic group, 2-[(18)F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino(oxy)-functionalised Aβ peptide.</pubmed_title><pmcid>PMC5034901</pmcid><funding_grant_id>MR/J012521/1</funding_grant_id><funding_grant_id>1233466</funding_grant_id><funding_grant_id>ARUK-PPG2012B-16</funding_grant_id><pubmed_authors>Allan S</pubmed_authors><pubmed_authors>Grigg J</pubmed_authors><pubmed_authors>Prenant C</pubmed_authors><pubmed_authors>McMahon A</pubmed_authors><pubmed_authors>Morris O</pubmed_authors><pubmed_authors>Boutin H</pubmed_authors><pubmed_authors>Allsop D</pubmed_authors><pubmed_authors>Henderson F</pubmed_authors><pubmed_authors>Gregory J</pubmed_authors><pubmed_authors>Blykers A</pubmed_authors><pubmed_authors>Kadirvel M</pubmed_authors><pubmed_authors>Taylor M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development &amp; automation of a novel [(18)F]F prosthetic group, 2-[(18)F]-fluoro-3-pyridinecarboxaldehyde, and its application to an amino(oxy)-functionalised Aβ peptide.</name><description>2-[(18)F]-Fluoro-3-pyridinecarboxaldehyde ([(18)F]FPCA) is a novel, water-soluble prosthetic group. It's radiochemistry has been developed and fully-automated for application in chemoselective radiolabelling of amino(oxy)-derivatised RI-OR2-TAT peptide, (Aoa-k)-RI-OR2-TAT, using a GE TRACERlab FX-FN. RI-OR2-TAT is a brain-penetrant, retro-inverso peptide that binds to amyloid species associated with Alzheimer's Disease. Radiolabelled (Aoa-k)-RI-OR2-TAT was reproducibly synthesised and the product of the reaction with FPCA has been fully characterised. In-vivo biodistribution of [(18)F]RI-OR2-TAT has been measured in Wistar rats.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2025-04-21T19:19:41.845Z</modification><creation>2019-03-27T02:25:00Z</creation></dates><accession>S-EPMC5034901</accession><cross_references><pubmed>27518217</pubmed><doi>10.1016/j.apradiso.2016.07.023</doi></cross_references></HashMap>